456 related articles for article (PubMed ID: 27574728)
1. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.
Ye BS; Seo SW; Kim CH; Jeon S; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Jang EY; Lee J; Kim JH; Chin J; Lee JM; Kim JH; Seong JK; Kim CH; Choe YS; Lee KH; Na DL
Neurobiol Aging; 2014 Feb; 35(2):291-300. PubMed ID: 24080178
[TBL] [Abstract][Full Text] [Related]
3. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
Jiménez-Bonilla JF; Banzo I; De Arcocha-Torres M; Quirce R; Martínez-Rodríguez I; Lavado-Pérez C; Bravo-Ferrer Z; Rodríguez-Rodríguez E; Sánchez-Juan P; Carril JM
Nucl Med Commun; 2016 Nov; 37(11):1189-96. PubMed ID: 27341411
[TBL] [Abstract][Full Text] [Related]
6. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC
PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589
[TBL] [Abstract][Full Text] [Related]
7. A biomarker study in long-lasting amnestic mild cognitive impairment.
Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
[TBL] [Abstract][Full Text] [Related]
9. Is there a difference in regional read [
Farrar G; Molinuevo JL; Zanette M
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1299-1308. PubMed ID: 30863934
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.
Seo EH; Choo IL;
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1088-95. PubMed ID: 26613793
[TBL] [Abstract][Full Text] [Related]
11. Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
Förster S; Buschert VC; Teipel SJ; Friese U; Buchholz HG; Drzezga A; Hampel H; Bartenstein P; Buerger K
J Alzheimers Dis; 2011; 26 Suppl 3():337-48. PubMed ID: 21971473
[TBL] [Abstract][Full Text] [Related]
12. Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment.
Gonzalez-Escamilla G; Atienza M; Garcia-Solis D; Cantero JL
Brain Struct Funct; 2016 Jan; 221(1):631-45. PubMed ID: 25366971
[TBL] [Abstract][Full Text] [Related]
13. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
Takemaru M; Kimura N; Abe Y; Goto M; Matsubara E
Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
[TBL] [Abstract][Full Text] [Related]
15. Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment.
Yoon HJ; Kim SG; Kim SH; Choo ILH; Park SH; Seo EH;
Yonsei Med J; 2019 Oct; 60(10):935-943. PubMed ID: 31538428
[TBL] [Abstract][Full Text] [Related]
16. Identifying Brain Connectivity Using Network-Based Statistics in Amnestic Mild Cognitive Impairment Stratified by β-Amyloid Positivity.
Kim JE; Kim SW; Choi M; Seong JK; Lee JH
Am J Alzheimers Dis Other Demen; 2019 Mar; 34(2):104-111. PubMed ID: 30497273
[TBL] [Abstract][Full Text] [Related]
17. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
Lim YY; Ellis KA; Harrington K; Pietrzak RH; Gale J; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P
J Alzheimers Dis; 2013; 33(4):1167-76. PubMed ID: 23160011
[TBL] [Abstract][Full Text] [Related]
18. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
19. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
[TBL] [Abstract][Full Text] [Related]
20. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]